International Stroke Conference 2025  /  Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20) - at the Neuro Talk Theater (AHA Head
Logo

American Heart Association

International Stroke Conference 2025

Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20) - at the Neuro Talk Theater (AHA Head

ISC Invited Symposium

Hall H&J, AHA HeadQuarters, Neuro Talk Theater

Feb 6th , 03:40 PM - 04:00 PM

Showing 0 Results.